|
AU1941501A
(en)
*
|
1999-11-30 |
2001-06-12 |
Parker Hughes Institute |
Syk localized at centrosome
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
US20040171062A1
(en)
*
|
2002-02-28 |
2004-09-02 |
Plexxikon, Inc. |
Methods for the design of molecular scaffolds and ligands
|
|
ES2445208T3
(es)
|
2002-07-29 |
2014-02-28 |
Rigel Pharmaceuticals, Inc. |
Compuestos de 2,4-pirimidindiamina para uso en métodos para tratar o prevenir enfermedades autoinmunitarias
|
|
AU2003272548A1
(en)
*
|
2002-09-16 |
2004-04-30 |
Plexxikon, Inc. |
Crystal structure of pim-1 kinase
|
|
US20050282814A1
(en)
*
|
2002-10-03 |
2005-12-22 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
|
WO2004083203A1
(en)
*
|
2003-03-13 |
2004-09-30 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as protein kinase inhibitors
|
|
US20050014753A1
(en)
*
|
2003-04-04 |
2005-01-20 |
Irm Llc |
Novel compounds and compositions as protein kinase inhibitors
|
|
CA2530389A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Biofocus Discovery Limited |
Pyrazine and pyridine derivatives as rho kinase inhibitors
|
|
EP1648875A1
(en)
*
|
2003-07-30 |
2006-04-26 |
Cyclacel Limited |
2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
|
|
BRPI0413018B8
(pt)
|
2003-07-30 |
2021-05-25 |
Rigel Pharmaceuticals Inc |
composto, e, uso de um composto
|
|
WO2005061519A1
(en)
*
|
2003-12-19 |
2005-07-07 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
|
KR20070011458A
(ko)
*
|
2004-04-08 |
2007-01-24 |
탈자진 인코포레이티드 |
키나제의 벤조트리아진 억제제
|
|
WO2005105788A1
(en)
*
|
2004-04-23 |
2005-11-10 |
Takeda San Diego, Inc. |
Indole derivatives and use thereof as kinase inhibitors
|
|
US7531556B2
(en)
|
2004-04-28 |
2009-05-12 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of rock and other protein kinases
|
|
LT3305776T
(lt)
*
|
2004-05-14 |
2020-01-10 |
Vertex Pharmaceuticals Incorporated |
Pirolo junginiai kaip erk baltymo kinazės inhibitoriai, ir farmacinės kompozicijos su šiais junginiais
|
|
EP1778669A2
(en)
*
|
2004-08-18 |
2007-05-02 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
|
PL382308A1
(pl)
|
2004-08-25 |
2007-08-20 |
Targegen, Inc. |
Związki heterocykliczne i sposoby stosowania
|
|
WO2006034207A2
(en)
*
|
2004-09-17 |
2006-03-30 |
Vanderbilt University |
Use of gsk3 inhibitors in combination with radiation therapies
|
|
ATE479687T1
(de)
|
2004-10-15 |
2010-09-15 |
Takeda Pharmaceutical |
Kinaseinhibitoren
|
|
US7968574B2
(en)
*
|
2004-12-28 |
2011-06-28 |
Kinex Pharmaceuticals, Llc |
Biaryl compositions and methods for modulating a kinase cascade
|
|
DE602006010979D1
(de)
|
2005-01-19 |
2010-01-21 |
Rigel Pharmaceuticals Inc |
Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
|
|
WO2006093247A1
(ja)
|
2005-02-28 |
2006-09-08 |
Japan Tobacco Inc. |
Ｓｙｋ阻害活性を有する新規なアミノピリジン化合物
|
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
NZ563984A
(en)
*
|
2005-06-08 |
2011-11-25 |
Targegen Inc |
Methods and compositions for the treatment of ocular disorders
|
|
WO2006133426A2
(en)
|
2005-06-08 |
2006-12-14 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
US20060281788A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
|
|
US7825244B2
(en)
|
2005-06-10 |
2010-11-02 |
Janssen Pharmaceutica Nv |
Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
|
|
US8071768B2
(en)
|
2005-06-10 |
2011-12-06 |
Janssen Pharmaceutica, N.V. |
Alkylquinoline and alkylquinazoline kinase modulators
|
|
EP1896134A2
(en)
|
2005-06-13 |
2008-03-12 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for treating degenerative bone disorders
|
|
PL1734251T3
(pl)
*
|
2005-06-17 |
2007-05-31 |
Magneti Marelli Powertrain Spa |
Wtryskiwacz paliwa
|
|
US20090176837A1
(en)
*
|
2005-07-12 |
2009-07-09 |
Sony Corporation |
Compounds with activity at retinoic acid receptors
|
|
US8211919B2
(en)
*
|
2005-09-02 |
2012-07-03 |
Astellas Pharma Inc. |
Amide derivatives as rock inhibitors
|
|
US7512864B2
(en)
*
|
2005-09-30 |
2009-03-31 |
Josef Zeevi |
System and method of accessing non-volatile computer memory
|
|
US8119655B2
(en)
*
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
KR101443651B1
(ko)
|
2005-10-18 |
2014-09-23 |
얀센 파마슈티카 엔.브이. |
Ｆｌｔ-3 키나제의 억제 방법
|
|
US8604042B2
(en)
*
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US8133900B2
(en)
*
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
CN103626742B
(zh)
|
2005-11-01 |
2017-04-26 |
塔格根公司 |
激酶的联-芳基间-嘧啶抑制剂
|
|
US20070149508A1
(en)
*
|
2005-11-02 |
2007-06-28 |
Targegen, Inc. |
Six membered heteroaromatic inhibitors targeting resistant kinase mutations
|
|
KR20080110998A
(ko)
*
|
2006-01-30 |
2008-12-22 |
엑셀리시스, 인코포레이티드 |
Ｊａｋ２ 조절자로서 ４아릴２아미노피리미딘 또는 4아릴２아미노알킬피리미딘 및 이들을 포함하는 약제학적 조성물
|
|
CA2642229C
(en)
|
2006-02-24 |
2015-05-12 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
US7834178B2
(en)
*
|
2006-03-01 |
2010-11-16 |
Bristol-Myers Squibb Company |
Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
|
|
ES2369739T3
(es)
|
2006-03-20 |
2011-12-05 |
Seikagaku Corporation |
Agente terapéutico para la artritis reumatoide.
|
|
ES2394348T3
(es)
|
2006-03-29 |
2013-01-30 |
Velacor Therapeutics Pty Ltd |
Tratamiento de enfermedades neurodegenerativas con selenato
|
|
US8697716B2
(en)
|
2006-04-20 |
2014-04-15 |
Janssen Pharmaceutica Nv |
Method of inhibiting C-KIT kinase
|
|
NZ572073A
(en)
|
2006-04-20 |
2011-09-30 |
Janssen Pharmaceutica Nv |
Heterocyclic compounds as inhibitors of c-fms kinase
|
|
BRPI0710548B8
(pt)
|
2006-04-20 |
2021-05-25 |
Janssen Pharmaceutica Nv |
inibidores de c-fms cinase, composição farmacêutica e forma de dosagem farmacêutica
|
|
EP2041071B1
(en)
|
2006-06-29 |
2014-06-18 |
Kinex Pharmaceuticals, LLC |
Biaryl compositions and methods for modulating a kinase cascade
|
|
US8030487B2
(en)
|
2006-07-07 |
2011-10-04 |
Targegen, Inc. |
2-amino—5-substituted pyrimidine inhibitors
|
|
SG158147A1
(en)
|
2006-10-09 |
2010-01-29 |
Takeda Pharmaceutical |
Kinase inhibitors
|
|
EP2223925A1
(en)
*
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
WO2008065155A1
(en)
*
|
2006-11-30 |
2008-06-05 |
Ingenium Pharmaceuticals Gmbh |
Cdk inhibitors for treating pain
|
|
US7935697B2
(en)
|
2006-12-28 |
2011-05-03 |
Kinex Pharmaceuticals, Llc |
Compositions for modulating a kinase cascade and methods of use thereof
|
|
HRP20151386T1
(hr)
|
2007-03-12 |
2016-02-26 |
Ym Biosciences Australia Pty Ltd |
Fenil aminopirimidinski spojevi i njihova primjena
|
|
WO2008119109A1
(en)
|
2007-03-29 |
2008-10-09 |
Velacor Therapeutics Pty Ltd |
Treatment of neurological disorders
|
|
US8445686B2
(en)
|
2007-08-27 |
2013-05-21 |
Abbvie Inc. |
4-(4-pyridinyl)-benzamides and their use as rock activity modulators
|
|
JO3240B1
(ar)
|
2007-10-17 |
2018-03-08 |
Janssen Pharmaceutica Nv |
c-fms مثبطات كيناز
|
|
US8309566B2
(en)
|
2008-02-15 |
2012-11-13 |
Rigel Pharmaceuticals, Inc. |
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
|
|
US20110189308A1
(en)
*
|
2008-03-17 |
2011-08-04 |
Asa Abeliovich |
Methods to treat neurodegenerative conditions or diseases by targeting components of a pten signaling pathway
|
|
MX2010011463A
(es)
|
2008-04-16 |
2011-06-03 |
Portola Pharm Inc |
2,6-diamino-pirimidin-5-il-carboxamidas como inhibidores de syk o jak quinasas.
|
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
NZ588830A
(en)
|
2008-04-22 |
2012-11-30 |
Portola Pharm Inc |
Inhibitors of protein kinases
|
|
EP2285989B1
(en)
|
2008-05-15 |
2016-11-16 |
The University of North Carolina At Chapel Hill |
Novel targets for regulation of angiogenesis
|
|
WO2009154697A2
(en)
|
2008-05-28 |
2009-12-23 |
Massachusetts Institute Of Technology |
Disc-1 pathway activators in the control of neurogenesis
|
|
US8513242B2
(en)
|
2008-12-12 |
2013-08-20 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimidine compounds and methods of making and using same
|
|
CN102438993A
(zh)
*
|
2009-05-19 |
2012-05-02 |
陶氏益农公司 |
用于控制真菌的化合物和方法
|
|
SG181857A1
(en)
|
2009-12-23 |
2012-07-30 |
Takeda Pharmaceutical |
Fused heteroaromatic pyrrolidinones as syk inhibitors
|
|
US9109227B2
(en)
|
2010-01-05 |
2015-08-18 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
FLT3 receptor antagonists for the treatment or the prevention of pain disorders
|
|
MX2012008083A
(es)
|
2010-01-12 |
2012-08-15 |
Ab Science |
Inhibidores de triazol y oxazol quinaza.
|
|
US8334292B1
(en)
|
2010-06-14 |
2012-12-18 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimidine compounds and methods of making and using same
|
|
UA114592C2
(uk)
*
|
2010-09-28 |
2017-07-10 |
Ноно Інк. |
Пептид nd2 та спосіб лікування неврологічного захворювання
|
|
US9102625B2
(en)
|
2010-11-01 |
2015-08-11 |
Portola Pharmaceuticals, Inc. |
Nicotinamides as JAK kinase modulators
|
|
CA2816957A1
(en)
|
2010-11-07 |
2012-05-10 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
|
AU2011328237A1
(en)
*
|
2010-11-09 |
2013-05-23 |
Cellzome Limited |
Pyridine compounds and aza analogues thereof as TYK2 inhibitors
|
|
JP6133790B2
(ja)
|
2011-02-18 |
2017-05-24 |
ザ スクリプス リサーチ インスティテュート |
ミエリン形成細胞運命へのオリゴデンドロサイト前駆細胞の定方向分化
|
|
JP6026525B2
(ja)
|
2011-06-22 |
2016-11-16 |
武田薬品工業株式会社 |
置換６−アザ−イソインドリン−１−オン誘導体
|
|
DE102011112978A1
(de)
*
|
2011-09-09 |
2013-03-14 |
Merck Patent Gmbh |
Benzonitrilderivate
|
|
CA3094793A1
(en)
|
2011-11-23 |
2013-05-30 |
Portola Pharmaceuticals, Inc. |
Pyrazine kinase inhibitors
|
|
JP6378171B2
(ja)
|
2012-04-24 |
2018-08-22 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
Ｄｎａ−ｐｋ阻害剤
|
|
US8809359B2
(en)
|
2012-06-29 |
2014-08-19 |
Ym Biosciences Australia Pty Ltd |
Phenyl amino pyrimidine bicyclic compounds and uses thereof
|
|
JP6290884B2
(ja)
|
2012-08-07 |
2018-03-07 |
ヤンセン ファーマシューティカ エヌ．ベー． |
ｃ−ＦＭＳキナーゼ阻害剤の調製プロセス
|
|
IN2015DN00659A
(https=)
|
2012-08-07 |
2015-06-26 |
Janssen Pharmaceutica Nv |
|
|
CN102827085A
(zh)
*
|
2012-09-17 |
2012-12-19 |
符爱清 |
2,4,5-三氯嘧啶化合物的制备方法
|
|
JP6407504B2
(ja)
|
2012-09-21 |
2018-10-17 |
アログ・ファーマシューティカルズ・インコーポレイテッドＡｒｏｇ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
恒常的に活性であるリン酸化型ｆｌｔ３キナーゼの阻害方法
|
|
US9676756B2
(en)
|
2012-10-08 |
2017-06-13 |
Portola Pharmaceuticals, Inc. |
Substituted pyrimidinyl kinase inhibitors
|
|
BR112015016282A2
(en)
|
2013-01-07 |
2017-07-11 |
Arog Pharmaceuticals, Inc. |
crenolanib for treatment of mutated flt3 proliferative disorders
|
|
SI3527563T1
(sl)
|
2013-03-12 |
2022-01-31 |
Vertex Pharmaceuticals Incorporated |
Inhibitorji DNA-PK
|
|
RU2675270C2
(ru)
|
2013-10-17 |
2018-12-18 |
Вертекс Фармасьютикалз Инкорпорейтед |
Сокристаллы и содержащие их фармацевтические композиции
|
|
US10463658B2
(en)
|
2013-10-25 |
2019-11-05 |
Videra Pharmaceuticals, Llc |
Method of inhibiting FLT3 kinase
|
|
AU2014342338B2
(en)
|
2013-11-01 |
2016-12-01 |
Novartis Ag |
Aminoheteroaryl benzamides as kinase inhibitors
|
|
EP3079682A4
(en)
|
2013-12-13 |
2017-08-30 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
US9856223B2
(en)
|
2013-12-13 |
2018-01-02 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
TWI729644B
(zh)
|
2014-06-12 |
2021-06-01 |
美商西爾拉癌症醫學公司 |
N-(氰基甲基)-4-(2-(4-𠰌啉基苯基胺基)嘧啶-4-基)苯甲醯胺
|
|
CN107001283B
(zh)
|
2014-07-31 |
2021-05-25 |
国家健康与医学研究院 |
Flt3受体拮抗剂
|
|
EP3193904B1
(en)
*
|
2014-08-18 |
2025-10-01 |
Cornell University |
Dipeptidomimetics as inhibitors of human immunoproteasomes
|
|
US10112957B2
(en)
|
2014-10-22 |
2018-10-30 |
Dana-Farber Cancer Institute, Inc. |
Thiazolyl-containing compounds for treating proliferative diseases
|
|
ES2854707T3
(es)
*
|
2015-02-04 |
2021-09-22 |
Beyondbio Inc |
Compuesto heterocíclico y composición farmacéutica que comprende el mismo
|
|
LT3319959T
(lt)
|
2015-07-06 |
2021-12-27 |
Alkermes, Inc. |
Histono deacetilazės hetero-halogeno inhibitoriai
|
|
EP3319968A1
(en)
|
2015-07-06 |
2018-05-16 |
Rodin Therapeutics, Inc. |
Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
|
|
EP3254698A1
(en)
|
2016-06-08 |
2017-12-13 |
Universite De Montpellier |
Flt3 receptor inhibitor at low dosage for the treatment of neuropathic pain
|
|
RU2758669C2
(ru)
|
2016-09-27 |
2021-11-01 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ лечения рака с применением сочетания днк-поражающих агентов и ингибиторов днк-пк
|
|
US12534764B2
(en)
|
2016-11-02 |
2026-01-27 |
Arog Pharmaceuticals, Inc. |
Crenolanib for treating FLT3 mutated proliferative disorders associated mutations
|
|
BR112019008762A2
(pt)
|
2016-11-02 |
2019-07-16 |
Arog Pharmaceuticals, Inc. |
método para o tratamento de um distúrbio proliferativo mutado em flt3
|
|
RS62959B1
(sr)
|
2017-01-11 |
2022-03-31 |
Alkermes Inc |
Biciklični inhibitori histon-deacetilaze
|
|
ES2952265T3
(es)
|
2017-05-02 |
2023-10-30 |
Novartis Ag |
Terapia combinada que comprende un inhibidor de Raf y trametinib
|
|
WO2018211018A1
(en)
|
2017-05-17 |
2018-11-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Flt3 inhibitors for improving pain treatments by opioids
|
|
WO2018217766A1
(en)
|
2017-05-22 |
2018-11-29 |
Whitehead Institute For Biomedical Research |
Kcc2 expression enhancing compounds and uses thereof
|
|
US11225475B2
(en)
|
2017-08-07 |
2022-01-18 |
Alkermes, Inc. |
Substituted pyridines as inhibitors of histone deacetylase
|
|
WO2019057649A1
(en)
|
2017-09-19 |
2019-03-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA
|
|
CN110833551B
(zh)
*
|
2018-08-15 |
2023-03-24 |
广西梧州制药（集团）股份有限公司 |
吡唑并嘧啶衍生物在治疗急性胰腺炎的用途
|
|
AU2019364336B2
(en)
|
2018-10-22 |
2023-11-16 |
Alumis Inc. |
TYK2 inhibitors and uses thereof
|
|
US12208098B2
(en)
|
2018-11-26 |
2025-01-28 |
Gachon University Of Industry-Academic Cooperation Foundation |
4-carbonylamino-4-phenylpyrimidine compound or pharmaceutically acceptable salt thereof
|
|
EP3920885A1
(en)
|
2019-02-08 |
2021-12-15 |
Frequency Therapeutics, Inc. |
Valproic acid compounds and wnt agonists for treating ear disorders
|
|
ES3025633T3
(en)
|
2019-05-13 |
2025-06-09 |
Novartis Ag |
New crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2(trifluoromethyl)isonicotinamide as raf inhibitors for the treatment of cancer
|
|
WO2022019998A1
(en)
|
2020-07-20 |
2022-01-27 |
Arog Pharmaceuticals, Inc. |
Crystal forms of crenolanib and methods of use thereof
|
|
WO2022090547A1
(en)
|
2020-10-30 |
2022-05-05 |
Dsm Ip Assets B.V. |
Production of carotenoids by fermentation
|
|
US11969420B2
(en)
|
2020-10-30 |
2024-04-30 |
Arog Pharmaceuticals, Inc. |
Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders
|
|
CN115677595B
(zh)
*
|
2022-10-26 |
2024-06-14 |
江苏睿实生物科技有限公司 |
一种2,4,5-三氯嘧啶的制备方法
|
|
CN116751191B
(zh)
*
|
2023-05-19 |
2025-09-16 |
凌科药业(杭州)有限公司 |
一种吡唑基-氨基-嘧啶基衍生物的晶型、制备方法及应用
|
|
KR20250075302A
(ko)
*
|
2023-11-21 |
2025-05-28 |
(주)신테카바이오 |
크레놀라닙 또는 이의 약학적으로 허용 가능한 염을 포함하는 아토피 피부염의 예방 또는 치료용 조성물
|
|
WO2025221087A1
(ko)
*
|
2024-04-19 |
2025-10-23 |
인제대학교 산학협력단 |
피디케이원 조절제 화합물 및 그를 포함하는 조성물
|
|
WO2026024674A1
(en)
|
2024-07-22 |
2026-01-29 |
Genesis Therapeutics, Inc. |
Methods of treating skp2-associated cancers
|